[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

YU74201A - Nova sinteza prstena piperazina - Google Patents

Nova sinteza prstena piperazina

Info

Publication number
YU74201A
YU74201A YU74201A YUP74201A YU74201A YU 74201 A YU74201 A YU 74201A YU 74201 A YU74201 A YU 74201A YU P74201 A YUP74201 A YU P74201A YU 74201 A YU74201 A YU 74201A
Authority
YU
Yugoslavia
Prior art keywords
piperazine ring
arylalkoxy
aryloxy
alkoxy
aryl
Prior art date
Application number
YU74201A
Other languages
English (en)
Inventor
Ben-Zion Dolitzky
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of YU74201A publication Critical patent/YU74201A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Opisan je novi postupak za pripremanje jedinjenja formule (I) naznačenog time što R1 označava supstituisani ili nesupstituisani alkil, alkoksi, aril, ariloksi ili arilalkoksi, R2 označava supstituisani ili nesupstituisani alkil, alkoksi, aril, ariloksi, arilalkoksi, tozil, formil, acetil ili amin, a R3 označava supstituisani ili nesupstituisani alkil, alkoksi, aril, ariloksi ili arilalkoksi. Ova jedinjenja su korisna u sintezi antidepresiva mirtazapina i drugih tetracikličnih jedinjenja.
YU74201A 1999-04-19 2000-04-07 Nova sinteza prstena piperazina YU74201A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13004899P 1999-04-19 1999-04-19

Publications (1)

Publication Number Publication Date
YU74201A true YU74201A (sh) 2004-05-12

Family

ID=22442818

Family Applications (1)

Application Number Title Priority Date Filing Date
YU74201A YU74201A (sh) 1999-04-19 2000-04-07 Nova sinteza prstena piperazina

Country Status (19)

Country Link
US (2) US6339156B1 (sh)
EP (1) EP1178972A4 (sh)
JP (1) JP2002542234A (sh)
KR (1) KR20020015313A (sh)
CN (1) CN1355793A (sh)
AU (1) AU777105B2 (sh)
CA (1) CA2370389A1 (sh)
CZ (1) CZ20013698A3 (sh)
HK (1) HK1042696A1 (sh)
HR (1) HRP20010759A2 (sh)
HU (1) HUP0200808A3 (sh)
IL (1) IL146024A0 (sh)
PL (1) PL351395A1 (sh)
RU (1) RU2001128228A (sh)
SK (1) SK14802001A3 (sh)
TR (1) TR200103035T2 (sh)
WO (1) WO2000063185A1 (sh)
YU (1) YU74201A (sh)
ZA (1) ZA200108480B (sh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146024A0 (en) * 1999-04-19 2002-07-25 Teva Pharma Novel synthesis of piperazine ring
AU6476300A (en) 1999-09-30 2001-05-10 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a piperazine derivative
AU6474200A (en) * 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
CA2460571A1 (en) * 2001-09-14 2003-03-27 Medichem S.A. Intermediate compounds for the preparation of mirtazapine and obtention methods thereof
US7041826B2 (en) * 2003-06-02 2006-05-09 Aurobindo Pharma Ltd. Process for preparing 1-methyl-3-phenylpiperazine using a novel intermediate
CN102126982A (zh) * 2005-09-26 2011-07-20 住友化学株式会社 光学活性的哌嗪化合物的制造方法
CN101440067B (zh) * 2007-11-21 2010-08-25 上海津力化工有限公司 一种药物中间体1-甲基-3-苯基哌嗪的制备方法
CN102649779A (zh) * 2012-04-20 2012-08-29 山东鲁药制药有限公司 一种药物中间体1-甲基-3-苯基哌嗪的合成方法
RS62055B1 (sr) 2015-02-27 2021-07-30 Dechra Ltd Stimulacija apetita, upravljanje gubitkom težine i lečenje anoreksije kod pasa i mačaka

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2891063A (en) * 1959-06-16 Piperazine derivatives and process of
US2830056A (en) * 1958-04-08 Chj oh
US2507408A (en) * 1948-03-05 1950-05-09 Rhone Poulenc Sa 1-alkylsulfonyl-4-alkyl piperazines
GB1181322A (en) * 1967-06-29 1970-02-11 Chugai Pharmaceutical Co Ltd Piperazine Derivatives and processes for preparing the same
NL179906C (nl) 1974-02-09 1986-12-01 Akzo Nv Werkwijze voor het bereiden van 1,2,3,4,10,14b-hexahydrodibenzo(c,f)pyrazino (1,2-a)azepine derivaten.
US4217452A (en) * 1974-02-09 1980-08-12 Akzona Incorporated Synthesis for the preparation of tetracyclic compounds
NL189199C (nl) 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
FR2585702B1 (fr) * 1985-07-31 1989-03-03 Lafon Labor Derives de phenyl-piperazine, procede de preparation et utilisation en therapeutique
US4918190A (en) * 1986-08-06 1990-04-17 Ube Industries, Ltd. Crystalline complex compounds of propargyl alcohols and tertiary diamines, and process of separation and purification of propargyl alcohols using the same
US4935515A (en) 1988-02-23 1990-06-19 American Home Products Corporation 2,3,4,5-tetrahydro-1H-[1,2,5]triazocino(1,2-a)[1,2,4]benzotriazin-7(8H)-ones, thiones and derivatives
IL146024A0 (en) * 1999-04-19 2002-07-25 Teva Pharma Novel synthesis of piperazine ring

Also Published As

Publication number Publication date
SK14802001A3 (sk) 2002-07-02
HUP0200808A2 (hu) 2002-11-28
AU4219000A (en) 2000-11-02
IL146024A0 (en) 2002-07-25
EP1178972A4 (en) 2002-06-12
CZ20013698A3 (cs) 2002-05-15
ZA200108480B (en) 2003-01-29
US6339156B1 (en) 2002-01-15
CN1355793A (zh) 2002-06-26
RU2001128228A (ru) 2003-07-20
HK1042696A1 (zh) 2002-08-23
US6852855B2 (en) 2005-02-08
TR200103035T2 (tr) 2002-01-21
US20020035256A1 (en) 2002-03-21
WO2000063185A1 (en) 2000-10-26
EP1178972A1 (en) 2002-02-13
HRP20010759A2 (en) 2003-02-28
AU777105B2 (en) 2004-09-30
HUP0200808A3 (en) 2002-12-28
KR20020015313A (ko) 2002-02-27
JP2002542234A (ja) 2002-12-10
CA2370389A1 (en) 2000-10-26
PL351395A1 (en) 2003-04-07

Similar Documents

Publication Publication Date Title
TW359670B (en) Process for producing quinazolin-4-one derivatives
GB0129476D0 (en) Organic compounds
DE60142934D1 (de) Pharmazeutische dopamin-glykokonjugat-zusammensetzungen und verfahren zu deren herstellung
IL113778A (en) Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof
YU74201A (sh) Nova sinteza prstena piperazina
MX9806246A (es) PIPERIDINAS NOVEDOSAS DERIVADAS DE 1-/(PIPERAZIN-1-IL)ARIL-(OXI/AMINO)CARBONIL(4-ARIL-PIPERIDIN A COMO ANTAGONISTAS SELECTIVOS DEL RECEPTOR 5-HT-1D- beta-.
HUP0004020A2 (hu) Triciklusos triazolo-benzazepin-származékok, eljárás a vegyületek előállítására és alkalmazásuk antiallergiás szerként
TNSN07357A1 (en) Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
MXPA04002569A (es) H6,7-dihidro-5h-pirazolo[1,2-a]pirazol-1-onas espirociclicas que controlan citocinas inflamatorias.
MXPA02012569A (es) Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas.
MEP12108A (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
DK1663970T3 (da) Matrixmetalloproteinaseinhibitorer
IL153682A0 (en) Variolin derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
EP0335979A4 (en) Thienopyrimidine derivatives
HUP0103020A2 (hu) Heterociklusos származékok mint FKBP inhibitorok, eljárás az előállításukra, köztitermékeik és ezeket tartalmazó gyógyszerkészítmények
HUP9800146A2 (hu) Thalidomidszármazékok, eljárás előállításukra és felhasználásuk
MXPA04001171A (es) Compuestos policiclicos condensados.
DE60210504D1 (de) Funktionalisierte höhere diamantoide
NO324252B1 (no) Fremgangsmate for fremstilling av en substituert imidazopyridinforbindelse
MY139258A (en) Carbamoyl-type benzofuran derivatives
BR0206650A (pt) Composto, composição farmacêutica, uso de pelo menos um composto, e, proceso para a preparação de um composto
HUP0400744A2 (hu) Piridoindolon származékok felhasználása rákellenes gyógyszerek előállítására
YU74501A (sh) Sinteza 3-amino-3-aril propionata
NO955071D0 (no) abeo-Ergolin-derivater som 5HT1A-ligander
MXPA03010597A (es) Derivados de triciclicos de dihidroquinolinas proceso para prepararlos y composiciones farmaceuticas que los contienen.